Literature DB >> 8566002

Epitopes for human CD4+ cells on diphtheria toxin: structural features of sequence segments forming epitopes recognized by most subjects.

R Raju1, D Navaneetham, D Okita, B Diethelm-Okita, D McCormick, B M Conti-Fine.   

Abstract

The sequence regions of diphtheria toxin (DTX) recognized by CD4+ T cells of seven healthy humans of different major histocompatibility complex haplotypes were identified. Overlapping synthetic peptides, screening the DTX sequence, were used to test in proliferation assays unselected blood CD4+ cells, or DTX-specific CD4+ lines propagated by stimulation with DTX of blood mononuclear cells. Blood CD4+ cells and DTX-specific CD4+ lines gave consistent results. Although each subject had an individual pattern of peptide recognition, six peptide sequences (residues 271-290, 321-340, 331-350, 351-370, 411-430 and 431-450) were recognized by all subjects. In the native DTX molecule, these sequence regions are flanked by sequence loops exposed on the DTX surface. They overlap uncharged segments of the DTX sequence. These structural properties may be general requirements for immunodominance in CD4+ cell sensitization in humans.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8566002     DOI: 10.1002/eji.1830251202

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  11 in total

1.  Interaction of dicaproyl phosphatidylserine with recombinant factor VIII and its impact on immunogenicity.

Authors:  Vivek S Purohit; Sathyamangalam V Balasubramanian
Journal:  AAPS J       Date:  2006-05-26       Impact factor: 4.009

2.  Phosphatidylserine reduces immune response against human recombinant Factor VIII in Hemophilia A mice by regulation of dendritic cell function.

Authors:  Puneet Gaitonde; Aaron Peng; Robert M Straubinger; Richard B Bankert; Sathy V Balu-Iyer
Journal:  Clin Immunol       Date:  2010-11-20       Impact factor: 3.969

3.  Three-dimensional structure determines the pattern of CD4+ T-cell epitope dominance in influenza virus hemagglutinin.

Authors:  Samuel J Landry
Journal:  J Virol       Date:  2007-12-05       Impact factor: 5.103

4.  Lower inhibitor development in hemophilia A mice following administration of recombinant factor VIII-O-phospho-L-serine complex.

Authors:  Vivek S Purohit; Karthik Ramani; Rita Sarkar; Haig H Kazazian; Sathyamangalam V Balasubramanian
Journal:  J Biol Chem       Date:  2005-02-23       Impact factor: 5.157

5.  Isolation and characterization of new human carrier peptides from two important vaccine immunogens.

Authors:  Paeton L Wantuch; Lina Sun; Rachel K LoPilato; Jarrod J Mousa; Robert S Haltiwanger; Fikri Y Avci
Journal:  Vaccine       Date:  2020-01-28       Impact factor: 3.641

6.  Molecular Cloning, Structural Modeling and the Production of Soluble Triple-Mutated Diphtheria Toxoid (K51E/G52E/E148K) Co-expressed with Molecular Chaperones in Recombinant Escherichia coli.

Authors:  Naphatsamon Uthailak; Pornpimol Mahamad; Pamorn Chittavanich; Somchai Yanarojana; Wassana Wijagkanalan; Jean Petre; Watanalai Panbangred
Journal:  Mol Biotechnol       Date:  2017-05       Impact factor: 2.695

7.  Prevention of experimental myasthenia gravis by nasal administration of synthetic acetylcholine receptor T epitope sequences.

Authors:  P I Karachunski; N S Ostlie; D K Okita; B M Conti-Fine
Journal:  J Clin Invest       Date:  1997-12-15       Impact factor: 14.808

8.  Identification of B- and T-cell epitopes of BB, a carrier protein derived from the G protein of Streptococcus strain G148.

Authors:  Liliane Goetsch; Jean Francois Haeuw; Thierry Champion; Christine Lacheny; Thien N'Guyen; Alain Beck; Nathalie Corvaia
Journal:  Clin Diagn Lab Immunol       Date:  2003-01

9.  Alphavirus-based hepatitis C virus therapeutic vaccines: can universal helper epitopes enhance HCV-specific cytotoxic T lymphocyte responses?

Authors:  Georgia Koutsoumpli; Peng Peng Ip; Ilona Schepel; Baukje Nynke Hoogeboom; Annemarie Boerma; Toos Daemen
Journal:  Ther Adv Vaccines Immunother       Date:  2019-10-03

10.  A Porphyromonas gingivalis Capsule-Conjugate Vaccine Protects From Experimental Oral Bone Loss.

Authors:  Fernanda G Rocha; Aym Berges; Angie Sedra; Shirin Ghods; Neeraj Kapoor; Lucy Pill; Mary Ellen Davey; Jeff Fairman; Frank C Gibson
Journal:  Front Oral Health       Date:  2021-07-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.